Cultural Integration in M&A

Most economists are predicting higher volumes for M&A over the next 12 months, albeit coming off a low base. In this article, Criticaleye’s Jacob Ambrose Willson hears from Matthew Parker, CEO of the highly acquisitive Babble, about the value of cultural integration in M&A.


Criticaleye supports senior leaders from a variety of businesses, sectors and geographies. With 83 percent of growth company executives in our research saying they are too inwardly focused, our global leadership Community provides a confidential and trusted space, offering diverse views which leaders can draw from when making decisions for themselves and their organisations. Click here to find out how we support growth company executives and non-executives.

 




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
Harnessing Real-time Data as ...

Paul Sheriff has successfully combined high level financial and operational leadership at several growth businesses since 2008. In this interview with Criticaleye’s Jacob Ambrose Willson, he discusses the nature o...

Click here to download this insight
Change Reinvented

In today's business landscape, continuous change is the new reality and navigating it effectively is essential to activating strategy and moving organisations forward. In this research, Criticaleye Partner, Accen...

Click here to download this insight
Driving Fast Growth via Priva...

Private equity ownership remains a highly attractive way for management teams to grow their businesses. Criticaleye’s Jacob Ambrose Willson asks Members with decades of experience working in PE about what to expec...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 1,259




E.ON UK Royal London Group Redwood Bank Drax Group plc Experian London Stock Exchange Lightsource bp Eton Bridge Partners Google Legal & General Investment Management Eightfold AI Mayborn Group Tullow Oil plc Workday Bunzl plc Salesforce LDC Concentrix Veolia Water Technologies Robert Walters Accenture AlixPartners Amazon UK GlaxoSmithKline plc NATS